SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis
Apoptosis · 2024
DOI: 10.1007/s10495-024-02009-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Ziyang Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postdoctoral Station of Medical Aspects of Specific Environments, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, P.R.…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis, Activating Transcription Factor 3. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Postdoctoral Fellowship Program of CPSF, National Natural Science Foundation of China.
Abstract (Originalsprache)
SEH1 like nucleoporin (SEH1L) is an important component of nuclear pore complex (NPC), which is crucial in the regulation of cell division. However, the interrelation between SEH1L expression and tumor progression is less studied. In this research, we performed a systematic bioinformatic analysis about SEH1L using TCGA, Timer 2.0, Cbioportal, UCLAN and CellMiner™ databases in pan-cancer. Besides, we further validated the bioinformatic results through in vitro and in vivo experiments in HCC, including transcriptome sequencing, real-time quantitative PCR (RT-qPCR), western blotting (WB), immunohistochemistry (IHC), cell proliferation assays, clone formation, EdU, transwell, flow cytometry and subcutaneous tumor model. Our results suggested that SEH1L was significantly up-regulated and related to poor prognosis in most cancers, and may serve as a potential biomarker. SEH1L could promote HCC progression in vitro and in vivo. Besides, the next generation sequencing suggested that 684 genes was significantly up-regulated and 678 genes was down-regulated after the knock down of SEH1L. SEH1L siliencing could activate ATF3/HMOX1/GPX4 axis, decrease mitochondrial membrane potential and GSH, but increase ROS and MDA, and these effects could be reversed by the knock down of ATF3. This study indicated that SEH1L siliencing could induce ferroptosis and suppresses hepatocellular carcinoma (HCC) progression via ATF3/HMOX1/GPX4 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postdoctoral Station of Medical Aspects of Specific Environments, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, P.R. China.
- Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, P.R. China.
- Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, P.R. China. aveinliu@163.com.
Förderung
- Natural Science Foundation of Hunan Province
- Postdoctoral Fellowship Program of CPSF
- National Natural Science Foundation of China
- Wisdom Gathering and Talent Cultivating Program from the Third Xiangya Hospital
Zitieren
APA
Feng, Z., Cao, K., Sun, H., & Liu, X. (2024). SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis. Apoptosis. https://doi.org/10.1007/s10495-024-02009-5
Vancouver
Feng Z, Cao K, Sun H, Liu X. SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis. Apoptosis. 2024. doi:10.1007/s10495-024-02009-5
BibTeX
@article{Feng2024,
author = {Feng, Ziyang and Cao, Ke and Sun, Haojia and Liu, Xuewen},
title = {SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis},
journal = {Apoptosis},
year = {2024},
doi = {10.1007/s10495-024-02009-5}
}
EUVIMED